| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/04/2009 | EP2029060A1 Amphiphilic peptides and hydrogel matrices thereof for bone repair |
| 03/04/2009 | EP2028932A2 Transgenic flies expressing tau and amyloid precursor fragment |
| 03/04/2009 | EP1706486B1 Chimeric empty capsids of the infectious bursal disease virus (ibdv), obtainment process and applications |
| 03/04/2009 | EP1695983B1 Glucagon-like peptide-1 analogs |
| 03/04/2009 | EP1650301B1 Gene imparting redifferentiation ability of plant and utilization of the same |
| 03/04/2009 | EP1599222B1 Stabilized aqueous compositions comprising tissue factor pathway inhibitor (tfpi) or tissue factor pathway inhibitor variant |
| 03/04/2009 | EP1560915B1 Assay methods for state-dependent calcium channel agonists/antagonists |
| 03/04/2009 | EP1519957B1 Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair |
| 03/04/2009 | EP1506222B1 Chimeric human papillomavirus 16 l1 proteins comprising an l2 peptide, virus-like particles prepared therefrom and a method for preparing the particles |
| 03/04/2009 | EP1499736B1 Improved chimeric glycoproteins and pseudotyped lentiviral vectors |
| 03/04/2009 | EP1463758B1 Mammalian prolactin variants |
| 03/04/2009 | EP1401863B1 Somatostatin-dopamine chimeric analogs |
| 03/04/2009 | EP1379269B1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease |
| 03/04/2009 | EP1294876B1 Eg-vegf nucleic acids and polypeptides and methods of use |
| 03/04/2009 | EP1255845B1 Modified cytokines for use in cancer therapy |
| 03/04/2009 | EP1248797B1 Process for the separation of antithrombin-iii isoforms |
| 03/04/2009 | EP1246917B1 Human stra6 polypeptides |
| 03/04/2009 | EP1181366B1 Mammalian receptor proteins; related reagents and methods |
| 03/04/2009 | EP1078006B1 Diagnosis and treatment of hepatic disorders |
| 03/04/2009 | EP1045861B1 Bispecific targeting moiety comprising an antibody to carcinoembryonic antigen (cea) and the ligand-binding region of the il13 receptor alpha subunit |
| 03/04/2009 | EP1037918B1 Compositions to enhance the efficacy of a vaccine using chemokines |
| 03/04/2009 | EP1021542B1 Apo-3 ligand |
| 03/04/2009 | EP1019085B1 Non-anaphylactic forms of allergens and their use |
| 03/04/2009 | EP0869974B1 Compounds with growth hormone releasing properties |
| 03/04/2009 | CN101379192A Anti-Met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products |
| 03/04/2009 | CN101379191A Methods and compositions for increasing the nitrogen storage capacity of a plant |
| 03/04/2009 | CN101379189A Modified coagulation factor VIIa with extended half-life |
| 03/04/2009 | CN101379084A Novel anticoagulant polypeptides and complex |
| 03/04/2009 | CN101379083A Apoptosis-induced protein compound and therapy application thereof |
| 03/04/2009 | CN101379082A Pharmaceutical composition for treating vascular-related diseases comprising peptide |
| 03/04/2009 | CN101379081A Soybean nodulation factor receptor proteins, encoding nucleic acids and uses therefor |
| 03/04/2009 | CN101379080A Nucleic acids and methods for producing seeds having a full diploid complement of the maternal genome in the embryo |
| 03/04/2009 | CN101379079A Peptide domain required for interaction between the envelope of a virus pertaining to the HERV-W interference group and an hASCT receptor |
| 03/04/2009 | CN101379078A Treatment of Epstein-Barr virus-associated diseases |
| 03/04/2009 | CN101379075A Synthesis of glucagon-like peptide |
| 03/04/2009 | CN101378783A Methods and compositions for expanding T regulatory cells |
| 03/04/2009 | CN101378773A Stable protein formulations |
| 03/04/2009 | CN101376885A Method for producing recombinant canine interferon alpha from cultivated silkworm |
| 03/04/2009 | CN101376879A Recombinant new castle disease LaSota attenuated vaccine strain expressing bovine interferon (alpha, beta and gamma-interferon) |
| 03/04/2009 | CN101376875A Pichia yeast expressing recombinant human blood coagulation factor VII, and preparation and use thereof |
| 03/04/2009 | CN101376676A PEGylated erythropoietin protein long-acting preparation |
| 03/04/2009 | CN101376675A Antimicrobial peptide |
| 03/04/2009 | CN101376674A Rice flavoprotein gene and use |
| 03/04/2009 | CN101376673A Rice fat synthesis related gene and use thereof |
| 03/04/2009 | CN100465272C A genetic engineering for recombining scorpion venom rBmKaIT1 |
| 03/04/2009 | CN100465190C A plant anti-reverse related protein, coding genes and an application thereof |
| 03/04/2009 | CN100465189C Thinopyrum intermedium disease-resistance-related protein NPR1, coding genes and an application thereof |
| 03/03/2009 | US7499847 Using computer program to apply molecular modeling techniques to coordinates; identifying whether compound interacts with human VAP-1 protein; use of structural information of crystalline human VAP-1 for ligand and/or inhibitor identification, design and production, in vitro screening assays |
| 03/03/2009 | US7498483 Expression vector comprising nucleotide sequences coding transferase for use in enhancing triacylglycerols concentration in seeds |
| 03/03/2009 | US7498482 Polynucleotide encoding polypeptide of given sequence; transformation to drought-resistant crops |
| 03/03/2009 | US7498479 Animal model having a chimeric human liver |
| 03/03/2009 | US7498424 Bioassy for identifying compounds which prevent host proteins interation with viral protein associated with infection, replication, assembly or release; viricides |
| 03/03/2009 | US7498417 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy |
| 03/03/2009 | US7498413 Polypeptide having fungicidal activity against Colletotrichum, Diplodia, or Fusarium; applying by spraying, dusting, seed coating or broadcasting |
| 03/03/2009 | US7498412 Process for preparing porous collagen matrix from connective tissue |
| 03/03/2009 | US7498409 Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists |
| 03/03/2009 | US7498408 Ryanodine receptor polypeptides |
| 03/03/2009 | US7498407 Vascular endothelial cell growth inhibitor, VEGI-192a |
| 03/03/2009 | US7498404 Purified, heat stable, amino terminus-methylated, carboxy-terminus reduced peptide isolated from Brevibacillus comprising {4-methyl-4-[-2-butenyl]-4,N-methyl-Threonine}-leucine-ornithine-isoleucine-valine-valine-lysine-valine-lysine-tyrosine-leucine-valine alcohol; immunomodulators; infections |
| 03/03/2009 | US7498308 The analogs are resistant to diaminopeptidase IV degradation and bind zinc; are active over an extended time in vivo |
| 03/03/2009 | US7498306 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents |
| 03/03/2009 | US7498305 Activated protein C variants with normal cytoprotective activity but reduced anticoagulant activity |
| 03/03/2009 | US7498304 Angiogenesis-modulating compositions and uses |
| 03/03/2009 | US7498300 Corticotropin releasing factor peptide for use in the treatment of nervous system and hypertensive disorders |
| 03/03/2009 | US7498299 Optionally containing a recognition sequence for affinity purification; treating fibrotic liver disorders |
| 03/03/2009 | US7498167 Transgenic skin cell culture for treating burns, injuries and ulcers; grafts/surgery; wound healing agents; tissue engineering |
| 03/03/2009 | US7498165 Rapidly cleavable SUMO fusion protein expression system for difficult to express proteins |
| 03/03/2009 | US7498162 A gene expressed polypeptide is used in food, for treating food allergy |
| 03/03/2009 | US7498158 Termamyl-like alpha-amylase for starch conversion, ethanol, laundry, dish, hard surface cleaning, textile desizing and/or sweetner production |
| 03/03/2009 | US7498157 Polypeptide crystal having a polyhistidine tag added to the C-terminal end; effectors; drug screening for enzyme inhibitors; multiple sclerosis, diabetes, Grave's disease, rheumatic arthritis, AIDS, cancer, immunomodulators |
| 03/03/2009 | US7498154 Nucleotide sequences coding cytokine receptor for identifying modulators for prevention and treatment of infection, cell proliferative and autoimmune disorders |
| 03/03/2009 | US7498153 Chimeric immunogens |
| 03/03/2009 | US7498152 Interferon-alpha polypeptides and conjugates |
| 03/03/2009 | US7498151 Variant TLR4 nucleic acid and uses thereof |
| 03/03/2009 | US7498149 Proteins having effects of controlling cell migration and cell death |
| 03/03/2009 | US7498148 A site specific clostripain cleavage of single and multicopy polypeptides ( glucagon-like peptide) |
| 03/03/2009 | US7498146 Containing high-molecular vWF multimers and being free from low-molecular vWF molecules and proteolytic vWF degradation products; chromatographic purification of Factor VIII or a Factor VIII/vWF-complex, admixing a purified high-molecular fraction of vWF molecules; hemophilia A, von Willebrand Disease |
| 03/03/2009 | US7498143 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 03/03/2009 | US7498139 Using presence of procalcitonin or procalcitonin partial peptides to detect septicemia; determining proprotein concentrations in sample |
| 03/03/2009 | US7498138 Multimerization of HIV-1 Vif protein as a therapeutic target |
| 03/03/2009 | US7498129 Measuring changes in level of antigen recognizable by a monoclonal antibody or antigen binding fragment; monoclonal antibody is produced by hybridoma cell line; decreased level indicates a reduced tumor; diagnosis, cell purification |
| 03/03/2009 | US7498127 Drug screening for cytostatic agent intracellular signaling inhibitor such as antitumor agents, antirheumatic agents; cardiovascular disorders; producing within a cell a fragment of heparin binding-epidermal growth factor (HB-EGF); determination of nuclear export of PLZF protein |
| 03/03/2009 | US7498037 Expression vector comprising nucleotide sequences coding malarial proteins for use as tool in generating vaccines against plasmodial infection; immunotherapy; antimalarial agents |
| 03/03/2009 | US7498036 Optimized expression of HPV 58 L1 in yeast |
| 03/03/2009 | US7498034 Imaging, diagnosis and treatment of disease |
| 03/03/2009 | US7498027 Methods of treatment using human tumor necrosis factor receptor TR17 antibodies |
| 03/03/2009 | US7498021 Peptide that binds to integrins |
| 03/03/2009 | CA2420222C Orally administered peptides to ameliorate atherosclerosis |
| 03/03/2009 | CA2276108C Novel peptide, novel dna, and novel antibody |
| 03/03/2009 | CA2238278C Antigenic protein originating in malassezia |
| 03/03/2009 | CA2200342C Overexpression of mammalian and viral proteins |
| 02/28/2009 | CA2597151A1 Hiv vaccine |
| 02/26/2009 | WO2009026465A2 Composition and methods of making and using influenza proteins |
| 02/26/2009 | WO2009026393A2 Amino acid substituted molecules |
| 02/26/2009 | WO2009026353A1 Immunogen presenting hiv gp120 v3 loop in a conformation that induces broadly neutralizing antibodies |
| 02/26/2009 | WO2009026338A1 Intracellular reporters |
| 02/26/2009 | WO2009026303A1 Human c-fms antigen binding proteins |
| 02/26/2009 | WO2009026183A1 Use of chimeric hiv/siv gag proteins to optimize vaccine-induced t cell responses against hiv gag |
| 02/26/2009 | WO2009026172A2 New approach for designing diabetes drugs |
| 02/26/2009 | WO2009026155A2 Antimicrobial activity of bovine bactericidal/permeability-increasing protein (bpi) - derived peptides against gram-negative bacterial mastitis isolates |